JORDEN DAVID EMERSON

Chief Financial Officer

OtherM

US·SEC (Form 4)

Nuo Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by JORDEN DAVID EMERSON, Chief Financial Officer. Insider active across 1 companies, notably Nuo Therapeutics, Inc.. Cumulatively, 1 reports have been published. The latest transaction was filed on 29 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.

Declarations1 total

Executives◆GrantNNuo Therapeutics, Inc.36SEC

J

JORDEN DAVID EMERSONCEO/CFO

€10,02610,532 shares@ €0.9520.017% mcap100.0% of flow

Common Stock

SEC:0001437749-22-010382:0·29 Apr 2022

SEC ↗

1 of 1 declaration

About JORDEN DAVID EMERSON

David Emerson Jorden is the CEO/CFO of Nuo Therapeutics, Inc. He oversees the financial and strategic operations of the company. His role is essential to ensure the growth and sustainability of the organization.